Embedded Files
The prevalence of autism and attention deficit hyperactivity disorder in the UK: a targeted systematic review
Autism and attention deficit hyperactivity disorder (ADHD) are included in a wide variety of neurological and cognitive disorders referred to as neurodivergent conditions. Individuals with autism may experience diverse conditions within a spectrum medically classified as autism spectrum disorders (ASD).
The objective of this scoping review is to identify current literature reporting on prevalence of autism, attention deficit hyperactivity disorder (ADHD) with or without co-occurring learning disability in individuals of any age living in the United Kingdom. The review will aim to summarise reported prevalence estimates and examine the methodological characteristics of prevalence studies.
Review questions:
What is the current estimate of the prevalence of autism, ADHD with or without learning disabilities in the UK?
Which methodologies are used to determine prevalence estimates?
How do the estimates vary by age, sex/gender, race/ethnicity, region or setting?
Link to protocol (coming soon)
Medicines optimisation at care transitions for people living with Dementia: A qualitative systematic review of patient, carer and healthcare professional perspectives.
People with dementia often have complex and changing medication regimes and because of the nature of dementia, are not always able to manage these regimes themselves. It can also be a challenge for their carers - both paid and unpaid carers. Medication related harm is a global issue, highlighted by the World Health Organization, and the reduction of harm to patients is a priority. As well as knowing what we can do to ensure that communication works so that medications are taken safely and effectively, it is also important to understand how patients, carers and healthcare professionals think that communication works and how it could be improved.
The University of Sheffield research team will identify studies which look at what happens when people with dementia move between different settings for example their home, sheltered accommodation, a care or nursing home, a hospital or a hospice in terms of how healthcare professionals communicate with each other (and with patients and their carers) about the medicines that the people with dementia are taking.
Review questions:
What are the views of patients and carers about the factors that influence medicines optimisation at transitions of care for PLWD?
What are the views of healthcare professionals about the factors that influence medicines optimisation at transitions of care for PLWD?
What is the perceived impact on PLWD, healthcare professionals and carers when medicines are not managed/optimised at transitions of care?
Is there evidence relating to communication as a factor that impacts on medicines optimisation at transitions of care?
Can we map evidence on factors that influence medications optimisation onto existing frameworks of transitions of care?
For more information about this project visit the NIHR Funding and Awards Page.
Report abuse